# FDA 483 - Gland Pharma Limited - August 25, 2022

Source: https://www.globalkeysolutions.net/records/483/gland-pharma-limited/acb284bb-cd1b-40c4-86d2-0f3405335cdc

> FDA 483 for Gland Pharma Limited on August 25, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Gland Pharma Limited
- Inspection Date: 2022-08-25
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2022-08-25](https://www.globalkeysolutions.net/records/483/gland-pharma-limited/659b070d-8685-49e7-9ff5-b07b9396e2b6)
- [483 - 2019-05-16](https://www.globalkeysolutions.net/records/483/gland-pharma-limited/52dd0bf5-1011-4834-bbb4-578c4d924b1a)
- [483 - 2022-08-25](https://www.globalkeysolutions.net/records/483/gland-pharma-limited/cbd5ee58-0d35-4dc8-a3c5-c1f424b4f63a)
- [483 - 2022-08-25](https://www.globalkeysolutions.net/records/483/gland-pharma-limited/da4cedf5-2525-4290-be26-5a39116695eb)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/gland-pharma-limited/59f50811-1e26-459b-bcda-2cbe6f0c9fb9)

## Related Officers

- [Joshua J. Silvestri](https://www.globalkeysolutions.net/people/joshua-j-silvestri/433e29b3-ce5f-44d2-9984-7a6cb61e1824)

Company: https://www.globalkeysolutions.net/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd